Future Business of Assisted Reproductive Technologies (ART) Market
Assisted Reproductive Technology (ART) Market
Global Insight Services’ Global Assisted Reproductive Technology (ART) Market Report is the sole authoritative source for Assisted Reproductive Technology (ART) market intelligence. The report will provide you with an analysis of the impact of the latest market disruptions such as the Russian-Ukrainian war and Covid-19 on the market. The report provides qualitative analysis of the market using various frameworks such as Porters and PESTLE analysis. The report includes in-depth segmentation and market size data by categories, product types, applications, and geographies. The report also includes a comprehensive analysis of key issues, trends and drivers, restraints and challenges, competitive landscape, and recent events such as merger and acquisition activities in the market.
Assisted reproductive technology (ART) is a medical procedure used to help couples who are struggling to conceive. This may involve using fertility drugs to stimulate ovulation, retrieving eggs from the ovaries for in vitro fertilization, or using a donor egg or sperm. ART can be used for couples struggling with infertility due to age, sperm quality, or other factors.
Learn More About Assisted Reproductive Technologies (ART) Market Here: https://www.globalinsightservices.com/reports/assisted-reproductive-technology-art-market
There are a few key trends in assisted reproductive technology (ART). One is the trend towards more personalized and targeted treatments. This means that treatments are increasingly tailored to the specific needs of the patient, rather than a one-size-fits-all approach. This is possible thanks to advances in genetic testing and other diagnostic tools.
Another trend is the increasing use of minimally invasive techniques. This is especially beneficial for patients who may be reluctant to undergo more invasive procedures, such as surgery. Minimally invasive techniques often have shorter recovery times and fewer risks.
Finally, there is a trend towards more affordable treatments. This is due to a variety of factors, such as the increasing use of generic drugs and the development of newer, more cost-effective treatments.
The major drivers of the Assisted Reproductive Technology (ART) market are the rising prevalence of infertility, increasing number of women opting for ART procedures, and growing awareness of fertility treatments.
Infertility is a global problem, affecting over 48 million couples worldwide. In the United States, an estimated 6.7 million women between the ages of 15 and 44 have difficulty conceiving or carrying a pregnancy to term.
Request a sample copy of this research study: https://www.globalinsightservices.com/request-sample/GIS21521/
ART procedures are expensive and not covered by most insurance plans. The cost of a single cycle of in vitro fertilization (IVF) can range from $10,000 to $15,000. This, coupled with the emotional stress associated with fertility treatments, can deter many couples from taking antiretroviral therapy.
However, success rates for ART procedures have increased, with the live birth rate for IVF now estimated at around 35%. This, along with the growing awareness of fertility treatments, is expected to drive the ART market in the coming years.
The assisted reproductive technologies market is segmented on the basis of product, technology and region. By product, the market is categorized into Instrument, Accessory & Disposable and Reactive & Media. The instruments segment is further classified into sperm separation system, cryosystem, incubator, imaging system, egg aspiration pump, cabinet, micromanipulator, laser systems and others. The Reagents and Media segment is further divided into Cryopreservation Media, Sperm Processing Media, Egg Processing Media and Embryo Culture Media. By technology, it is divided into in vitro fertilization, artificial insemination and others.
Key Players of Assisted Reproductive Technologies Market include Cook Medical Inc., Fujifilm Holdings Corporation, Genea Biomedx, Merck KGaA, Millendo Therapeutics, Inc., Oxford Gene Technology, Progyny Inc., The Cooper Companies, Inc., Thermo Fisher Scientific , Inc. and Vitrolife AB.
Get a personalized report according to your needs: https://www.globalinsightservices.com/request-customization/GIS21521/
With Global Insight Services, you receive:
– 10-year forecasts to help you make strategic decisions
– In-depth segmentation that can be customized to your needs
– Free consultation with the lead analyst of the report
– Excel data pack included with all report purchases
– Robust and transparent research methodology
Global Insight Services LLC
16192 Coast Road, Lewes DE 19958
Email: [email protected]
About Global Insight Services:
Global Insight Services (GIS) is a leading multi-industry market research company headquartered in Delaware, USA. We are committed to providing our clients with the highest quality data, analysis and tools to meet all of their market research needs. With GIS, you can be assured of quality deliverables, a robust and transparent research methodology, and superior service.
This press release was published on openPR.